机构:[1]School of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Structural Biology, MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Tsinghua University, Beijing 100084, China[2]Beijing Advanced Innovation Center for Human Brain Protection, Beijing Tiantan Hospital, Capital Medical University, Beijing 100084, China首都医科大学附属天坛医院[3]Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore 138671, Singapore[4]State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China[5]National Center for Protein Science, School of Life Sciences, Tsinghua University, Beijing 100084, China[6]Center for Stem Cell Biology and Regenerative Medicine, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China[7]Collaborative Innovation Center for Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China四川大学华西医院
This research was supported by Bill & Melinda Gates
Foundation (OPP1213221 to L. Chen); Ministry of Science and Technology
of China, National Key R&D Program of China (2018YFA0506903 to L. Chen
); and the National Natural Science Foundation of China (91857108 and
81470839 to L. Chen).
第一作者机构:[1]School of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Structural Biology, MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Tsinghua University, Beijing 100084, China[2]Beijing Advanced Innovation Center for Human Brain Protection, Beijing Tiantan Hospital, Capital Medical University, Beijing 100084, China
通讯作者:
通讯机构:[1]School of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Structural Biology, MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Tsinghua University, Beijing 100084, China[2]Beijing Advanced Innovation Center for Human Brain Protection, Beijing Tiantan Hospital, Capital Medical University, Beijing 100084, China[7]Collaborative Innovation Center for Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China
推荐引用方式(GB/T 7714):
Wenhua Kuang,Jie Zhang,Zhou Lan,et al.SLC22A14 is a mitochondrial riboflavin transporter required for sperm oxidative phosphorylation and male fertility.[J].CELL REPORTS.2021,35(3):doi:10.1016/j.celrep.2021.109025.
APA:
Wenhua Kuang,Jie Zhang,Zhou Lan,R.N.V. Krishna Deepak,Chao Liu...&Ligong Chen.(2021).SLC22A14 is a mitochondrial riboflavin transporter required for sperm oxidative phosphorylation and male fertility..CELL REPORTS,35,(3)
MLA:
Wenhua Kuang,et al."SLC22A14 is a mitochondrial riboflavin transporter required for sperm oxidative phosphorylation and male fertility.".CELL REPORTS 35..3(2021)